TDI-11055

N/A

Report date: 2022/11/16 17:18:56
NME

Base Information

Drug NameTDI-11055
Drug Alias NameTDI-11055
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein ENL inhibitors
TargetsProtein ENL
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pennsylvania
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A